News
The StrataQuest software was coupled with TissueFAXS, offering a convenient workflow that could automatically acquire up to ...
Truist analyst David MacDonald raised the firm’s price target on Quest Diagnostics (DGX) to $190 from $182 and keeps a Hold rating on the ...
Barclays raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $175 and keeps an Equal Weight rating on the shares. The ...
A groundbreaking 'Declaration on Longevity and Precision Medicine' was launched at Abu Dhabi Global Health Week (ADGHW), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results